Clinical trial

Carbon-11 Acetate and Fludeoxyglucose F 18 PET Scan of the Bone in Patients With…

NCT00392938 · University of Washington, Other · Completed

Key facts

NCT number NCT00392938
Title Carbon-11 Acetate and Fludeoxyglucose F 18 PET Scan of the Bone in Patients With Metastatic Prostate Cancer That Has Spread to the Bone
Official title Positron Emission Tomography Imaging of Bone in Patients With Metastatic Prostate Cancer - A Pilot Study Evaluating Treatment Response
Lead sponsor University of Washington, Other
Collaborators National Cancer Institute (NCI) NIH
Status Completed
Study type Observational
Conditions Metastatic Cancer, Prostate Cancer
Intervention type Diagnostic Test, Drug
Interventions antiandrogen therapy, docetaxel, C-11 acetate PET scan, F-18 FDG PET scan, Tc-99m bone scan, CT scan of the chest, abdomen and pelvis
Enrollment 11
Start date Dec 1, 2005
Primary completion May 1, 2010
First posted Oct 26, 2006
Last update posted Mar 13, 2017
Countries United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies